Fig. 9
GULP1 predicts immunotherapy response and sensitive drugs. Based on the TISMO web tool, box line plots showing the expression of GULP1 in cancer cell lines before and after cytokine treatment (a), and the expression of GULP1 in cancer cell lines before and after PDL1 or CTLA4 treatment (b). *p < 0.05, **p < 0.01, ***p < 0.001. correlation analysis between GULP1 and CTL (c). ROC Plotter was applied to assess the predictive effect of GULP1 on the response to BRCA, OV, COADREAD, and GBM immunotherapy (d). The top 5 drugs showing positive or negative correlation with GULP1 expression based on drug sensitivity databases CTRP (e) and GDSC (f).
